Perkins Capital Management Inc Champions Oncology, Inc. Transaction History

Perkins Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$7.05 - $10.2 $144,525 - $209,099	-20,500 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$4.19 - $8.62 $73,325 - $150,850	-17,500 Reduced 46.05%	20,500 $152,000
Q4 2019 Feb 03, 2020	SELL	$5.12 - $8.33 $140,800 - $229,075	-27,500 Reduced 41.98%	38,000 $317,000
Q3 2019 Oct 23, 2019	SELL	$5.4 - $8.99 $416,070 - $692,679	-77,050 Reduced 54.05%	65,500 $370,000
Q2 2019 Aug 09, 2019	SELL	$7.51 - $10.12 $241,446 - $325,358	-32,150 Reduced 18.4%	142,550 $1.12 Million
Q4 2018 Feb 11, 2019	SELL	$7.29 - $15.27 $43,011 - $90,093	-5,900 Reduced 3.27%	174,700 $1.36 Million
Q3 2018 Oct 22, 2018	BUY	$5.82 - $17.47 $451,632 - $1.36 Million	77,600 Added 75.34%	180,600 $3.16 Million
Q2 2018 Aug 02, 2018	BUY	$3.6 - $7.27 $370,800 - $748,810	103,000 New	103,000 $653,000

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Perkins Capital Management Inc with notifications on news.